|
End-of-day quote
CBOE
|
||
| - EUR | - |
|
| 19/12/24 | Orapi SA(ENXTPA:ORAP) dropped from CAC AllShares Index | CI |
| 10/10/24 | Orapi: proposed public exchange offer filed with the AMF |
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.93 | 5.54 | 2.68 | 1.23 | -0.97 | |||||
Return on Total Capital | 1.44 | 8.18 | 4.02 | 1.86 | -1.49 | |||||
Return On Equity % | -6.97 | 19.12 | 0.67 | 1.53 | -35.49 | |||||
Return on Common Equity | -7.14 | 18.89 | 0.33 | 1.36 | -36.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 47.81 | 52.67 | 50.75 | 47.6 | 45.84 | |||||
SG&A Margin | 40.28 | 39.12 | 40.98 | 39.77 | 37.99 | |||||
EBITDA Margin % | 6.27 | 9.15 | 6.4 | 3.94 | 1.48 | |||||
EBITA Margin % | 1.52 | 7.21 | 4.19 | 1.88 | -0.99 | |||||
EBIT Margin % | 1.23 | 6.95 | 3.89 | 1.61 | -1.27 | |||||
Income From Continuing Operations Margin % | -1.21 | 3.54 | 0.17 | 0.4 | -8.01 | |||||
Net Income Margin % | -1.23 | 3.45 | 0.09 | 0.35 | -8.21 | |||||
Net Avail. For Common Margin % | -1.23 | 3.45 | 0.09 | 0.35 | -8.16 | |||||
Normalized Net Income Margin | -0.16 | 3.03 | 0.64 | 0.51 | -1.55 | |||||
Levered Free Cash Flow Margin | 7.35 | 8.7 | 4.95 | 0.28 | 6.11 | |||||
Unlevered Free Cash Flow Margin | 8.27 | 9.39 | 6.16 | 0.52 | 6.35 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.22 | 1.27 | 1.1 | 1.22 | 1.22 | |||||
Fixed Assets Turnover | 7.83 | 6.58 | 5.16 | 4.85 | 4.28 | |||||
Receivables Turnover (Average Receivables) | 5.32 | 6.31 | 5.81 | 6.15 | 6.1 | |||||
Inventory Turnover (Average Inventory) | 4.01 | 3.93 | 3.3 | 3.52 | 3.66 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.75 | 1.45 | 1.14 | 1.12 | 1.08 | |||||
Quick Ratio | 0.52 | 1.05 | 0.73 | 0.7 | 0.71 | |||||
Operating Cash Flow to Current Liabilities | 0.06 | 0.32 | 0.22 | 0.11 | 0.24 | |||||
Days Sales Outstanding (Average Receivables) | 68.57 | 58.03 | 62.81 | 59.32 | 59.83 | |||||
Days Outstanding Inventory (Average Inventory) | 91.1 | 93.07 | 110.7 | 103.76 | 99.7 | |||||
Average Days Payable Outstanding | 138.82 | 113.4 | 140.79 | 118.63 | 130.08 | |||||
Cash Conversion Cycle (Average Days) | 20.84 | 37.71 | 32.71 | 44.45 | 29.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 225.64 | 160.66 | 104 | 105.63 | 181.39 | |||||
Total Debt / Total Capital | 69.29 | 61.64 | 50.98 | 51.37 | 64.46 | |||||
LT Debt/Equity | 48.02 | 122.64 | 68.34 | 64.98 | 126.59 | |||||
Long-Term Debt / Total Capital | 14.75 | 47.05 | 33.5 | 31.6 | 44.99 | |||||
Total Liabilities / Total Assets | 78.95 | 74.29 | 67.69 | 68.07 | 77.08 | |||||
EBIT / Interest Expense | 0.83 | 6.35 | 2.02 | 4.25 | -3.31 | |||||
EBITDA / Interest Expense | 6.08 | 10.55 | 4.66 | 17.01 | 11.01 | |||||
(EBITDA - Capex) / Interest Expense | 4.85 | 8.52 | 3.09 | 7.5 | 3.92 | |||||
Total Debt / EBITDA | 4.27 | 3.03 | 3.05 | 4.37 | 7.92 | |||||
Net Debt / EBITDA | 3.83 | 1.81 | 2.52 | 3.75 | 6.55 | |||||
Total Debt / (EBITDA - Capex) | 5.35 | 3.76 | 4.6 | 9.9 | 22.22 | |||||
Net Debt / (EBITDA - Capex) | 4.8 | 2.24 | 3.8 | 8.51 | 18.38 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.19 | 11.42 | -15.28 | 1.31 | 0.89 | |||||
Gross Profit, 1 Yr. Growth % | -6.26 | 22.73 | -18.37 | -4.96 | -1.98 | |||||
EBITDA, 1 Yr. Growth % | 48.67 | 58.42 | -41.56 | -41.67 | -64.65 | |||||
EBITA, 1 Yr. Growth % | 31.48 | 555.18 | -51.59 | -50.97 | -162.64 | |||||
EBIT, 1 Yr. Growth % | 6.36 | 531.87 | -53.35 | -58.19 | -180.59 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -21.73 | -424.54 | -95.83 | 135.03 | -2.25K | |||||
Net Income, 1 Yr. Growth % | -21.24 | -411.46 | -97.88 | 312.82 | -2.44K | |||||
Normalized Net Income, 1 Yr. Growth % | 352.42 | -2.26K | -84.89 | -19.15 | -416.17 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -21.46 | -363.25 | -98.23 | 301.26 | -2.74K | |||||
Accounts Receivable, 1 Yr. Growth % | -11.37 | 0.17 | -16.29 | 10.01 | -7.89 | |||||
Inventory, 1 Yr. Growth % | -15.85 | 25.34 | -10.99 | 14.52 | -14.34 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 93.45 | 1.15 | 14.74 | 2.03 | 23.71 | |||||
Total Assets, 1 Yr. Growth % | -4.4 | 17.68 | -18.58 | 3.63 | -3.6 | |||||
Tangible Book Value, 1 Yr. Growth % | -26.98 | -161.7 | 93.88 | 15.46 | -34.94 | |||||
Common Equity, 1 Yr. Growth % | -6.55 | 43.52 | 1.21 | 2.43 | -31.68 | |||||
Cash From Operations, 1 Yr. Growth % | 293.04 | 293.47 | -40.8 | -45.83 | 105.24 | |||||
Capital Expenditures, 1 Yr. Growth % | -42.8 | 36.82 | 15.26 | 20.73 | -24.54 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -237.98 | 31.86 | -49.14 | -94.51 | 2.25K | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -280.05 | 26.44 | -44.86 | -91.79 | 1.18K | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -0.75 | 2.24 | -2.84 | -7.36 | 0.54 | |||||
Gross Profit, 2 Yr. CAGR % | -2.97 | 7.26 | 0.09 | -11.92 | -4.44 | |||||
EBITDA, 2 Yr. CAGR % | 14.9 | 55.5 | -3.15 | -39.63 | -53.3 | |||||
EBITA, 2 Yr. CAGR % | -7.41 | 163.98 | 79.58 | -53.02 | -49.38 | |||||
EBIT, 2 Yr. CAGR % | -16.73 | 159.24 | 73.18 | -55.84 | -42.58 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.31 | 59.38 | -63.23 | -68.7 | 582.37 | |||||
Net Income, 2 Yr. CAGR % | 18.53 | 56.62 | -74.33 | -70.44 | 882.36 | |||||
Normalized Net Income, 2 Yr. CAGR % | -30.96 | 889.35 | 96.57 | -65.05 | 56.69 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 18.32 | 43.79 | -78.45 | -73.35 | 879.53 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.46 | -5.78 | -8.43 | -4.04 | 0.66 | |||||
Inventory, 2 Yr. CAGR % | -8.37 | 2.7 | 5.62 | 0.96 | -0.96 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 39.89 | 39.88 | 7.73 | 8.2 | 12.35 | |||||
Total Assets, 2 Yr. CAGR % | -0.94 | 6.07 | -2.15 | -8.14 | -0.05 | |||||
Tangible Book Value, 2 Yr. CAGR % | -22.7 | -32.88 | 12.59 | 49.61 | -13.33 | |||||
Common Equity, 2 Yr. CAGR % | -7.09 | 15.81 | 20.97 | 1.82 | -16.35 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.9 | 293.26 | 52.63 | -43.37 | 9.24 | |||||
Capital Expenditures, 2 Yr. CAGR % | -30.2 | -11.53 | 25.58 | 17.96 | -4.55 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 175.2 | 34.88 | -20.25 | -82.92 | 9.28 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 124.4 | 50.88 | -16.17 | -78.34 | 0.34 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -1.09 | 3.15 | -3.97 | -1.48 | -5.04 | |||||
Gross Profit, 3 Yr. CAGR % | -3.12 | 4.93 | -2.07 | -1.62 | -9.33 | |||||
EBITDA, 3 Yr. CAGR % | 12.59 | 29.01 | 12.71 | -16.37 | -48.54 | |||||
EBITA, 3 Yr. CAGR % | 6.97 | 65.62 | 50.81 | 13.71 | -51.32 | |||||
EBIT, 3 Yr. CAGR % | -0.33 | 63.64 | 47.2 | 7.83 | -46.42 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 39.78 | 65.61 | -52.7 | -31.76 | 24.74 | |||||
Net Income, 3 Yr. CAGR % | 39.12 | 63.57 | -62.7 | -35.2 | 26.89 | |||||
Normalized Net Income, 3 Yr. CAGR % | 148.15 | 117.67 | 159.54 | 46.19 | -28.15 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 38.96 | 54.47 | -66.84 | -42.88 | 19.3 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.55 | -2.94 | -9.42 | -2.65 | -5.34 | |||||
Inventory, 3 Yr. CAGR % | -5.35 | 1.72 | -2.08 | 8.51 | -4.42 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 29.34 | 25.56 | 30.94 | 5.79 | 13.14 | |||||
Total Assets, 3 Yr. CAGR % | -0.5 | 4.92 | -2.9 | -0.26 | -6.65 | |||||
Tangible Book Value, 3 Yr. CAGR % | -13.2 | -28.29 | -2.54 | 13.54 | 13.35 | |||||
Common Equity, 3 Yr. CAGR % | -6.38 | 7.4 | 11 | 14.44 | -10.86 | |||||
Cash From Operations, 3 Yr. CAGR % | 37.4 | 65.05 | 109.2 | 8.06 | -10.94 | |||||
Capital Expenditures, 3 Yr. CAGR % | -4.73 | -12.65 | -3.38 | 23.94 | 1.64 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 96.14 | 115.35 | -4.27 | -66.83 | -14.07 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 222.96 | 85.34 | 8.16 | -60.9 | -16.84 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.74 | -0.71 | -1.79 | -1.19 | -2.19 | |||||
Gross Profit, 5 Yr. CAGR % | -0.82 | 0.25 | -1.85 | -2.16 | -3.03 | |||||
EBITDA, 5 Yr. CAGR % | 5.51 | 20.47 | 6.57 | -4.54 | -19.7 | |||||
EBITA, 5 Yr. CAGR % | -12.08 | 46.99 | 26.14 | 0.39 | -3.95 | |||||
EBIT, 5 Yr. CAGR % | -15.73 | 45.93 | 24.32 | -2.76 | 1.01 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.38 | 10.98 | -18.07 | -14.96 | 37.57 | |||||
Net Income, 5 Yr. CAGR % | 8.77 | 10.58 | -29.24 | -17.5 | 38.02 | |||||
Normalized Net Income, 5 Yr. CAGR % | -34.02 | 219.71 | 126.07 | 8.29 | 112.1 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 3.21 | 5.13 | -34.07 | -23.57 | 28.47 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.16 | -3.75 | -5.53 | -3.38 | -5.51 | |||||
Inventory, 5 Yr. CAGR % | -0.5 | -0.86 | -1.11 | 1.41 | -1.63 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.22 | 14.79 | 20.22 | 18.3 | 23.16 | |||||
Total Assets, 5 Yr. CAGR % | 3.76 | 1.95 | -1.16 | -0.53 | -1.77 | |||||
Tangible Book Value, 5 Yr. CAGR % | 36.29 | -15.77 | -3.68 | -2.64 | -7.01 | |||||
Common Equity, 5 Yr. CAGR % | -4.12 | 2.42 | 3.72 | 5.29 | -0.88 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.03 | 59.78 | 43.3 | 7.59 | 61.32 | |||||
Capital Expenditures, 5 Yr. CAGR % | -6.16 | -2.18 | 6.4 | -1.49 | -3.85 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 57.04 | 98.6 | 36.84 | -22.68 | 1.82 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 44.33 | 93.85 | 88.3 | -21.34 | 5.7 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | - |
- Stock Market
- Stocks
- ORAP Stock
- 0ICI Stock
- Financials ORAPI
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















